Dr. Suganthi. S
MBBS, MD, DM (Clinical Pharmacology)
Special Area of Interest:
Oncopharmacology, Clinical Pharmacology and Toxicology, Regulatory Pharmacology
- Muiwo P, Pandey P, Ahmad HM, Ramachandran SS, Bhattacharya A. IsomiR processing during differentiation of myelogenous leukemic cell line K562 by phorbol ester PMA. Gene. 2018 Jan 30;641:172-179.
- Ramachandran SS, Muiwo P, Ahmad HM, Pandey RM, Singh S, Bakhshi S, Kumar L, Bhattacharya A, Gupta YK. miR-505-5p and miR-193b-3p: potential biomarkers of imatinib response in patients with chronic myeloid leukemia. Leuk Lymphoma. 2017 Aug;58(8):1981-1984.
- Gupta YK, Ramachandran SS. Fixed dose drug combinations: Issues and challenges in India. Indian J Pharmacology 2016; 48:347-9.
- Ahmad HM, Muiwo P, Ramachandran SS, Pandey P, Gupta YK, Kumar L, Kulshreshtha R, Bhattacharya A. miR-22 regulates expression of oncogenic neuro-epithelial transforming gene 1, NET1. FEBS J. 2014 Sep; 281(17): 3904-19.
- Gupta YK, Ramachandran SS. Pharmacology of Aging, Textbook of Geriatric Medicine; 1st edition (2014), Paras Publishers, ISBN-10: 818191418X. (Book Chapter)